CXCL10 and Hashimoto thyroiditis: In a recent study by Yang et al., significantly higher plasma CXCL10/IP-10 levels were detected in the acute stage of DIHS/DRESS in patients with long-term sequelae, such as Hashimoto’s thyroiditis and fulminant type 1 diabetes mellitus, than in those without long-term sequelae or those with HHV-6 reactivation [46].